Miach Orthopaedics Granted FDA De Novo Approval for Treatment of ACL Tears

Miach Orthopaedics BEAR Implant

Miach Orthopaedics gained FDA De Novo approval for the bioengineered Bridge-Enhanced® ACL Repair (BEAR®) Implant for the treatment of anterior cruciate ligament (ACL) tears. Limited market release is slated for early 2021.

BEAR is the first medical technology to clinically demonstrate that it enables healing/restoration of a torn ACL. This...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us